An Activin receptor is a receptor which binds activin. These proteins are receptor-type kinases of Ser/Thr type, which have a single transmembrane domain and a specific hydrophilic Cys-rich ligand-binding domain.[1][2][3]
Types include:
- Activin type 1 receptors
- Activin type 2 receptors
Human proteins containing this domain
ACVR1; ACVR1B; ACVR1C; ACVR2A; ACVR2B; ACVRL1; BMPR1A; BMPR1B;
BMPR2; TGFBR1;
References
- ^ Wrana JL, Attisano L (1996). "Signal transduction by members of the transforming growth factor-beta superfamily". Cytokine Growth Factor Rev. 7 (4): 327–339. doi:10.1016/S1359-6101(96)00042-1. PMID 9023056.
- ^ Wrana JL, Attisano L, Wieser R, Ventura F, Massague J (1994). "Mechanism of activation of the TGF-beta receptor". Nature. 370 (6488): 341–347. doi:10.1038/370341a0. PMID 8047140. S2CID 4344481.
- ^ Massague J, Weis-Garcia F (1996). "Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals". Cancer Surv. 27: 41–64. PMID 8909794.
External links
- Activin+receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
|
|---|
| Type I cytokine receptor |
- Nerve growth factors: Ciliary neurotrophic factor
- Erythropoietin
|
|---|
| Receptor protein serine/threonine kinase | |
|---|
| Receptor tyrosine kinase | |
- Nerve growth factors: high affinity Trk
| |
- Somatomedin
- Insulin-like growth factor 1
|
- ErbB/Epidermal growth factor
| |
|
|---|
| Tumor necrosis factor receptor |
- Nerve growth factors: Low affinity/p75
|
|---|
| Ig superfamily |
- Platelet-derived growth factor
- Stem cell factor
|
|---|
| Other/ungrouped |
- Somatomedin
- Insulin-like growth factor 2
|
|---|
|
|---|
| TGF beta superfamily of ligands | | Ligand of or TGFBR | |
|---|
| Ligand of BMPR |
- Bone morphogenetic proteins
- BMP2
- BMP3
- BMP4
- BMP5
- BMP6
- BMP7
- BMP8a
- BMP8b
- BMP10
- BMP15
- Growth differentiation factors
- GDF1
- GDF2
- GDF3
- GDF5
- GDF6
- GDF7
- Myostatin/GDF8
- GDF9
- GDF10
- GDF11
- GDF15
- Anti-müllerian hormone
|
|---|
|
|---|
TGF beta receptors (, BMP, family) | | TGFBR1: |
- Activin type 1 receptors
- ACVRL1
- BMPR1
|
|---|
| TGFBR2: |
- Activin type 2 receptors
- AMHR2
- BMPR2
|
|---|
| TGFBR3: | |
|---|
|
|---|
| Transducers/SMAD |
- R-SMAD (SMAD1
- SMAD2
- SMAD3
- SMAD5
- SMAD9)
- I-SMAD (SMAD6
- SMAD7)
- SMAD4
|
|---|
| Ligand inhibitors |
- Cerberus
- Chordin
- Decorin
- Follistatin
- Gremlin
- Lefty
- LTBP1
- Noggin
- PARN
- THBS1
|
|---|
| Coreceptors | |
|---|
| Other | |
|---|
|
|---|
| Type I | | ALK1 (ACVRL1) |
- Agonists: Activin (A, B, AB)
- Avotermin
- BMP (10)
- Cetermin
- GDF (2 (BMP9))
- TGFβ (1, 2, 3)
- Kinase inhibitors: K-02288
- ML-347 (LDN-193719, VU0469381)
- Other inhibitors: Disitertide
|
|---|
| ALK2 (ACVR1A) |
- Agonists: Activin (A, B, AB)
- AMH (MIS)
- Avotermin
- BMP (5, 6, 7, 8A, 8B)
- Eptotermin alfa
- TGFβ (1, 2, 3)
- Kinase inhibitors: DMH-1
- DMH-2
- Dorsomorphin (BML-275)
- K-02288
- ML-347 (LDN-193719, VU0469381)
|
|---|
| ALK3 (BMPR1A) |
- Agonists: AMH (MIS)
- BMP (2, 4, 5, 6, 7, 8A, 8B)
- Dibotermin alfa
- Eptotermin alfa
- Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
|---|
| ALK4 (ACVR1B) |
- Agonists: Activin (A, B, AB)
- GDF (1, 3, 11 (BMP11))
- Myostatin (GDF8)
- Nodal
- Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
|---|
| ALK5 (TGFβR1) |
- Agonists: Avotermin
- GDF (10 (BMP3B), 11 (BMP11))
- TGFβ (1, 2, 3)
|
|---|
| ALK6 (BMPR1B) |
- Agonists: BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
- GDF (5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 15)
- Radotermin
- Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
|---|
| ALK7 (ACVR1C) |
- Agonists: GDF (1, 3, 11 (BMP11))
- Nodal
- Antagonists: Lefty (1, 2)
- Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
|---|
|
|---|
| Type II | | TGFβR2 |
- Agonists: Avotermin
- GDF (10 (BMP3B))
- TGFβ (1, 2, 3)
- Kinase inhibitors: DMH-2
- LY-364947
|
|---|
| BMPR2 |
- Agonists: BMP (2, 4, 6, 7, 10)
- Dibotermin alfa
- Eptotermin alfa
- GDF (2 (BMP9), 5 (BMP14), 6 (BMP13), 7 (BMP12))
- Radotermin
|
|---|
| ACVR2A (ACVR2) |
- Agonists: Activin (A, B, AB)
- BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 11 (BMP11), 15)
- Myostatin (GDF8)
- Nodal
- Radotermin
|
|---|
| ACVR2B |
- Agonists: Activin (A, B, AB)
- BMP (2, 4, 6, 7)
- Dibotermin alfa
- Eptotermin alfa
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12))
- Myostatin (GDF8)
- Nodal
- Osteogenin (BMP3, BMP3A)
- Radotermin
- Decoy receptors: Ramatercept
|
|---|
| AMHR2 (AMHR) | |
|---|
|
|---|
| Type III | |
|---|
| Unsorted |
- Endogenous antagonists/inhibitors: BAMBI
- Cerberus (CER1)
- Chordin
- DAN (PARN)
- Decorin
- Follistatin
- Gremlin (Drm)
- LTBP1
- Noggin
- TGIF
- Thrombospondin 1 (THBS1)
- Tomoregulin 1
- Antibodies: Stamulumab (against myostatin)
- TRC105 (against endoglin)
|
|---|
This article incorporates text from the public domain Pfam and InterPro:
IPR000472